Results 101 to 110 of about 13,620 (172)

Plant-Derived Carotenoid Lutein Demonstrates Multifunctional Antiviral Activity against Influenza A Virus <i>in vitro</i>. [PDF]

J Microbiol Biotechnol
Kim JW, Ryu HS, Lee S, Jeon S, Yoon SW, Jang YH.   +5 more
europepmc   +1 more source

The role of virus in nasal inflammation. [PDF]

Eur J Med Res
Wang C, Zhang YM, Li M, Cheng KJ.
europepmc   +1 more source

Effect of Seasonal Influenza Vaccines on Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Ferrets. [PDF]

Emerg Infect Dis
Sun X, Subbiah J, Belser JA, Brock N, Gansebom S, Li ZN, Jung YJ, Liu F, Tumpey TM, Maines TR, Levine MZ, York IA.   +11 more
europepmc   +1 more source

Ubiquitin E3 ligase MARCH10 targets influenza hemagglutinin for ubiquitination. [PDF]

Cell Signal
Tsai M, Koch D, Forchione A, Farkas L, El-Mergawy R, Londino JD, Mallampalli RK.   +6 more
europepmc   +1 more source

HA Protein acetylation modulates replication, pathogenicity, and immunogenicity of influenza virus and facilitates live-attenuated vaccine design. [PDF]

Emerg Microbes Infect
Wu M, Wang M, Zeng X, Zhang K, Wang M, Xu G, Wang Z, Cheng Y, Wang H, Yan Y, Sun J, Ma J.   +11 more
europepmc   +1 more source

Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutinin. [PDF]

Nat Commun
Alzua GP, León AN, Yellin T, Bhavsar D, Loganathan M, Bushfield K, Brouwer PJM, Rodriguez AJ, Jeevan T, Webby R, Marizzi C, Han J, Ward AB, Duty JA, Krammer F.   +14 more
europepmc   +1 more source

Development of Nanobody-Expressing Nanosomes for Neutralization of Influenza Virus. [PDF]

J Microbiol Biotechnol
Kim T, Jang IH, Shin S, Kang J, Ahn HJ, Moon S, Kim J, Ryu JH, Lee KA.   +8 more
europepmc   +1 more source

Genetic and Serological Analysis of H7N3 Avian Influenza Viruses in Mexico for Pandemic Risk Assessment. [PDF]

Viruses
Ayora-Talavera G, López-Martínez I, Barrera-Badillo G, Aparicio-Antonio R, Aréchiga-Ceballos N, Aguirre-Barbosa A, Wong-Chew RM, Canul-Canul D, Solís-Hernández M.   +8 more
europepmc   +1 more source

Brief Comparison of Novel Influenza Vaccine Design Strategies. [PDF]

Vaccines (Basel)
Chai S, Ye C, Fan C, Jiang H.
europepmc   +1 more source

Differences in Glycoproteins and the Potential for Early Protection Using LAIV Based on Drift Variants of the A/H1N1pdm09 Influenza Virus. [PDF]

Vaccines (Basel)
Desheva Y, Mayorova I, Rekstin A, Sokolovsky D, Kudar P, Kopylova N, Guzenkov D, Petrachkova D, Mamontov A, Trullioff A, Kiseleva I.   +10 more
europepmc   +1 more source